Shen et al showed that tumours with an ARID1A‐deficient ovarian cancer cell line origin in syngeneic mice displayed increased mutation load, enhanced levels of tumour‐infiltrating lymphocytes and up‐regulated PD‐L1 expression. Here, CD274 is linked to neoplasm.